Aj Vaccines A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.ajvaccines.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
6
CIMA_AEMPS:3
SFDA:2
EMC:1
Drug Approvals
DITEBOOSTER SUSPENSION INYECTABLE EN JERINGA MONODOSIS PRECARGADA
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
VACUNA BCG 0,75 mg/ml POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
Phase 4
Completed
- Conditions
- Poliomyelitis
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- AJ Vaccines A/S
- Target Recruit Count
- 163
- Registration Number
- NCT04448132
- Locations
- 🇵🇦
Cevaxim, Panama city, Panama
News
No news found